Lexotan

Bromazepam, the active ingredient in Lexotan, is a benzodiazepine presented as an oral dosage form for oral use. It is prescribed for the management of anxiety disorders and for short‑term relief of anxiety symptoms in adult patients. The compound acts on the central nervous system to produce anxiolytic, muscle‑relaxant and sedative effects.

GNH USA supplies Lexotan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved documentation to facilitate import, distribution and clinical use across multiple regions.

Bromazepam is indicated for anxiety‑related conditions and works by modulating the GABA‑A receptor pathway. - Generalized anxiety disorder: reduces excessive worry and tension in affected individuals. - Panic disorder: alleviates acute panic attacks and associated somatic symptoms. - Short‑term relief of anxiety symptoms: provides rapid symptom control during stressful periods or before medical procedures.

Bromazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general lack of energy or tiredness. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control and clumsiness.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with high doses or CNS depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Withdrawal symptoms: anxiety, tremor, seizures upon abrupt discontinuation after prolonged use.

When prescribing bromazepam, clinicians should consider several safety precautions to minimize risks. - Assess patient history: evaluate for prior substance abuse, depression or respiratory disorders. - Avoid abrupt discontinuation: taper the dose gradually to prevent withdrawal phenomena. - Use caution with CNS depressants: limit concurrent use of alcohol, opioids or other sedatives. - Monitor elderly patients: increased sensitivity may lead to falls or cognitive impairment. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Bromazepam can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Opioids: combined CNS depression may cause profound respiratory depression. - Barbiturates: additive sedative effects increase risk of profound sedation. - Antifungal azoles (e.g., ketoconazole): may increase bromazepam plasma levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance serotonergic effects and increase sedation. - Antihistamines: additive drowsiness may impair alertness. - Anticonvulsants (e.g., carbamazepine): may reduce bromazepam concentrations, decreasing efficacy.